Baseline clinical characteristics, (n=16)
| Characteristics | Value |
|---|---|
| Age (years), mean±SD | 70±12 |
| Female sex | 7 (44) |
| NIHSS score on admission, median (IQR) | 17 (15–23) |
| Cerebrovascular risk factors | |
| Atrial fibrillation | 8 (50) |
| Coronary artery disease or MI | 4 (25) |
| Intracranial atherosclerosis | 3 (19) |
| Diabetes mellitus | 6 (38) |
| Hypertension | 13 (81) |
| Dyslipidemia | 10 (63) |
| Smoker | 3 (19) |
| Prior stroke | 3 (19) |
| Location of occlusion | |
| MCA M1 | 5 (31) |
| MCA M2/3 | 5 (31) |
| ICA-T | 3 (19) |
| ACA A2 | 1 (6) |
| BA | 2 (13) |
| PCA | 1 (6) |
| Procedural data | |
| IV rtPA administration | 7 (44) |
| General anesthesia | 6 (38) |
| Time from symptom onset to femoral puncture (min), median | 260 |
| Procedure duration (min), median | 62 |
Results are shown as n (%) unless stated otherwise. ACA A2, anterior cerebral artery A2 segment; BA, basilar artery; ICA-T, internal carotid artery terminus; MCA M1, middle cerebral artery M1 segment; MCA M2/3, middle cerebral artery M2/3 segment, MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Scale; PCA, posterior cerebral artery, rtPA recombinant tissue plasminogen activator.